ALK and hereditary clear cell renal cell carcinoma: In fact, using high-sensitivity anti-ALK immunohistochemistry (iAEP method) as screening, we have identified several novel ALK fusions in various types of cancers including lung adenocarcinoma [11], lymphoma [28], sarcoma [35], and renal cell carcinoma [30].